ReviewFrontiers in pharmacology2016

Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging.

Linda K Mooberry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.